News Breaks |
|
|
| November 19, 2012 |
| 09:13 EDT |  | GSK, LGND | GlaxoSmithKline says FDA approves new indication for Promacta
GlaxoSmithKline (GSK) announced that the U.S. Food and Drug Administration has approved Promacta for the treatment of thrombocytopenia, or low blood platelet counts, in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy. There are limitations to the use of PROMACTA in patients suffering from chronic hepatitis C-associated thrombocytopenia, the company noted. |
|
|
News For GSK;LGND From The Last 14 Days Check below for free stories on GSK;LGND the last two weeks. |
|
|
| June 18, 2013 |
| 08:37 EDT |  | GSK | Drug companies turn to microchips to test medicines, WSJ reports
 Subscribe for More Information |
|
| 07:13 EDT | | GSK | Aspen in talks buy GSK's Arixtra, Fraxiparine brands
Subscribe for More Information |
|
| 07:07 EDT | | GSK | GlaxoSmithKline receives offer for thrombosis brands from Aspen
GlaxoSmithKline said it received an offer for its thrombosis brands and Notre-Dame de Bondeville site from Aspen Global. A period of exclusivity has been agreed with Aspen. The financial terms are confidential at this time, but the offer includes the transfer of the Arixtra and Fraxiparine brands to Aspen, along with the related manufacturing site and the majority of employees at NDB in France and certain dedicated commercial employees, GSK said. "The proposed transaction is aligned to GSK's strategy of focusing on products with the most growth potential and the delivery of its pipeline," the company added. |
|
| June 12, 2013 |
| 19:54 EDT | | GSK | GlaxoSmithKline investigates bribe claims in China, WSJ says
Subscribe for More Information |
|
| 07:16 EDT | | GSK | GlaxoSmithKline fires head of R&D in China, WSJ says
GlaxoSmithKline has fired it's head of R&D in China after finding that he had incorporated "misinterpreted" data in a paper he helped write for a journal, Nature Medicine, according to The Wall Street Journal, citing the company. Reference Link |
|
| June 6, 2013 |
| 15:59 EDT | | GSK | FDA votes for modified restrictions on GSK's Avandia, Reuters says
Subscribe for More Information |
|
| 15:42 EDT | | GSK | FDA panel revote reaffirms modified restrictions for GSK's Avandia, Reuters says
|
|
| 15:26 EDT | | GSK | FDA advisers say Glaxo Avandia vote may have been inaccurate, Bloomberg says
Advisers plan to take a break to assess problem with vote tally and plan to re-vote on GSK's Avandia after break, Bloomberg says. |
|
| 15:20 EDT | | GSK | FDA panel votes to modify market restrictions for Avandia, Reuters says
Subscribe for More Information |
|
|
|
|
|
